Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providing
superior returns to their investors.
ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.
Industries: Biotechnology
Health Care
Medical
Biopharma
Fitness
Wellness
Genetics
Health Diagnostics
Therapeutics
Analytics
Pharmaceutical
Investment Stages: Late Stage Venture
Early Stage Venture
Location: San Francisco, California, United States
